Appointment of Joint Broker

RNS Number : 7732X
Oxford Instruments PLC
01 September 2022
 

 

 

Oxford Instruments plc

Appointment of Joint Broker

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, today announces that it has appointed Numis Securities Limited to act as its joint corporate broker alongside JP Morgan Cazenove.

 

 

Enquiries:

 

Oxford Instruments plc      Tel:  01865 393200

Ian Barkshire, Group Chief Executive

Gavin Hill, Chief Financial Officer

 

Numis Securities Limited       Tel:  020 7260 1000

Mark Lander/Andrew Coates

 

MHP Communications   Tel:  020 3128 8100

Katie Hunt/Peter Lambie/Charlie Protheroe

oxfordinstruments@mhpc.com

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

 

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 60 years, supporting its core purpose to address some of the world's most pressing challenges. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its strategy focuses on being a customer-centric, market-focused Group, understanding the technical and commercial challenges faced by its customers. Key market segments include Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased connectivity, improved health and leaps in scientific understanding. Their advanced products and services allow the world's leading industrial companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level, helping to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries.

 

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPKFLBXLVLZBBV
UK 100